Daiichi Sankyo Transfers Shizuoka Factory To CMIC
This article was originally published in PharmAsia News
Daiichi Sankyo announced July 31 it will transfer its ProPharma factory in Shizuoka Prefecture to Japanese contract research organization CMIC. The transfer will take place April 2010. As a part of a production site consolidation, Daiichi Sankyo will also shut down a factory in Osaka city by March 2011. After the factory transfer and closing, the group will concentrate manufacturing in five domestic factories. (Click here for more - Japanese language
You may also be interested in...
Public Company Edition: Four health care special purpose acquisition vehicles went public and two others announced mergers, but only one biopharma firm priced an IPO during the week of 19-23 October. Replimune’s $250m offering led recent FOPOs.
Wholesalers are given three more years to set up electronic systems to verify saleable returns under another reprieve from the FDA. Yet the reprieve does not extend to manufacturers, who must respond within 24 hours to wholesalers’ requests to manually verify that a returned product is not suspect.
Agency explains how it will model vaccine authorization process on its licensing process for matters like inspections and lot release.